Bolinger A, Li J, Xie X, Li H, Zhou J
Expert Opin Drug Discov. 2024; 19(9):1023-1041.
PMID: 39078037
PMC: 11390334.
DOI: 10.1080/17460441.2024.2385598.
Rombini M, Cecchini D, Diana Menendez S, Calanni L, Cuini R, Obieta E
Viruses. 2023; 15(5).
PMID: 37243213
PMC: 10223653.
DOI: 10.3390/v15051127.
Yilmaz G, Bulut H, Ozden Omaygenc D, Akca A, Can E, Tuten N
Acta Biomed. 2023; 94(1):e2023007.
PMID: 36786260
PMC: 9987489.
DOI: 10.23750/abm.v94i1.13655.
Dadashi M, Dadashi A, Sameni F, Sayadi S, Goudarzi M, Nasiri M
Gene Rep. 2022; 27:101624.
PMID: 35607389
PMC: 9117161.
DOI: 10.1016/j.genrep.2022.101624.
Ashour N, Elmaaty A, Sarhan A, Elkaeed E, Moussa A, Erfan I
Drug Des Devel Ther. 2022; 16:685-715.
PMID: 35321497
PMC: 8935998.
DOI: 10.2147/DDDT.S354841.
SARS-CoV-2 at the human-animal interphase: A review.
Farag E, Islam M, Enan K, El-Hussein A, Bansal D, Haroun M
Heliyon. 2021; 7(12):e08496.
PMID: 34869934
PMC: 8626158.
DOI: 10.1016/j.heliyon.2021.e08496.
Current Potential Therapeutic Approaches against SARS-CoV-2: A Review.
Yadav D, Singh D, Han I, Kumar Y, Choi E
Biomedicines. 2021; 9(11).
PMID: 34829850
PMC: 8615922.
DOI: 10.3390/biomedicines9111620.
IgG seroprevalence of COVID-19 among people living with HIV or at high risk of HIV in south-west Germany: A seroprevalence study.
Kaddu-Mulindwa D, Keuser L, Lesan V, Rissland J, Smola S, Werdecker V
HIV Med. 2021; 23(5):564-569.
PMID: 34811869
PMC: 9011579.
DOI: 10.1111/hiv.13207.
Clinical features and mechanistic insights into drug repurposing for combating COVID-19.
Asrani P, Tiwari K, Eapen M, McAlinden K, Haug G, Johansen M
Int J Biochem Cell Biol. 2021; 142:106114.
PMID: 34748991
PMC: 8570392.
DOI: 10.1016/j.biocel.2021.106114.
Predicted antiviral drugs Darunavir, Amprenavir, Rimantadine and Saquinavir can potentially bind to neutralize SARS-CoV-2 conserved proteins.
Halder U
J Biol Res (Thessalon). 2021; 28(1):18.
PMID: 34344455
PMC: 8331326.
DOI: 10.1186/s40709-021-00149-2.
Tenofovir, Another Inexpensive, Well-Known and Widely Available Old Drug Repurposed for SARS-COV-2 Infection.
Zanella I, Zizioli D, Castelli F, Quiros-Roldan E
Pharmaceuticals (Basel). 2021; 14(5).
PMID: 34064831
PMC: 8150375.
DOI: 10.3390/ph14050454.
Comparison of outcomes in HIV-positive and HIV-negative patients with COVID-19.
Venturas J, Zamparini J, Shaddock E, Stacey S, Murray L, Richards G
J Infect. 2021; 83(2):217-227.
PMID: 34051225
PMC: 8152212.
DOI: 10.1016/j.jinf.2021.05.020.
COVID-19 and HIV infection co-pandemics and their impact: a review of the literature.
Gatechompol S, Avihingsanon A, Putcharoen O, Ruxrungtham K, Kuritzkes D
AIDS Res Ther. 2021; 18(1):28.
PMID: 33952300
PMC: 8097669.
DOI: 10.1186/s12981-021-00335-1.
Efficacy and Effect of Inhaled Adenosine Treatment in Hospitalized COVID-19 Patients.
Caracciolo M, Correale P, Mangano C, Foti G, Falcone C, Macheda S
Front Immunol. 2021; 12:613070.
PMID: 33815368
PMC: 8012541.
DOI: 10.3389/fimmu.2021.613070.
COVID-19 in People Living with HIV: A Systematic Review and Meta-Analysis.
Lee K, Yap S, Ngeow Y, Lye M
Int J Environ Res Public Health. 2021; 18(7).
PMID: 33808066
PMC: 8037457.
DOI: 10.3390/ijerph18073554.
Pharmacological considerations for the treatment of COVID-19 in people living with HIV (PLWH).
Gutierrez M, Mur I, Gracia Mateo M, Vidal F, Domingo P
Expert Opin Pharmacother. 2021; 22(9):1127-1141.
PMID: 33634724
PMC: 7919104.
DOI: 10.1080/14656566.2021.1887140.
Antivirals for COVID-19: A critical review.
Frediansyah A, Tiwari R, Sharun K, Dhama K, Harapan H
Clin Epidemiol Glob Health. 2021; 9:90-98.
PMID: 33521390
PMC: 7831805.
DOI: 10.1016/j.cegh.2020.07.006.
COVID-19 in Immunocompromised Hosts: What We Know So Far.
Fung M, Babik J
Clin Infect Dis. 2021; 72(2):340-350.
PMID: 33501974
PMC: 7337668.
DOI: 10.1093/cid/ciaa863.
A review of potential suggested drugs for coronavirus disease (COVID-19) treatment.
Tarighi P, Eftekhari S, Chizari M, Sabernavaei M, Jafari D, Mirzabeigi P
Eur J Pharmacol. 2021; 895:173890.
PMID: 33482181
PMC: 7816644.
DOI: 10.1016/j.ejphar.2021.173890.
A systematic review of contemporary evidence on SARS-CoV-2 and HIV coinfection: What does it look like up to date?.
Shareef M, Bashaiwth H, AlAkbari A, Bahamran M, Alamodi M, Albaiti S
Avicenna J Med. 2021; 10(4):189-197.
PMID: 33437690
PMC: 7791285.
DOI: 10.4103/ajm.ajm_175_20.
